ENDRA Life Sciences (NDRA) Share-based Compensation Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Share-based Compensation Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 2.20% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 985.46% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 58.33% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 8.31% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -7.84% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -21.41% |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 7,538.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,538.57% |
| Mar 31, 2026 | 3,535.97% |
| Dec 31, 2025 | -98.06% |
| Sep 30, 2025 | 37,450.18% |
| Jun 30, 2025 | -94.18% |
| Mar 31, 2025 | -73.84% |
| Dec 31, 2024 | -58.22% |
| Sep 30, 2024 | -99.96% |
| Jun 30, 2024 | 5.06% |
| Mar 31, 2024 | -50.90% |
| Dec 31, 2023 | -13.83% |
| Sep 30, 2023 | -92.20% |
| Jun 30, 2023 | -91.92% |
| Mar 31, 2023 | -91.88% |
| Dec 31, 2022 | -29.38% |
| Sep 30, 2022 | 124.27% |
| Mar 31, 2022 | 2,373.91% |
| Dec 31, 2021 | -24.19% |
| Sep 30, 2021 | 610.94% |
| Mar 31, 2021 | -37.01% |